Alcides is a Cell Bio graduate, finishing a PhD in Neuroscience. Writes about life sciences, pharma, and biotech.
Under looked biotech company might be near tipping point
The Danish multinational offers an exciting growth opportunity.
The US government has selected three vaccine candidates to fund their Phase 3 trials through Operation Warp Speed.
